Matt Popkin, PhD

GlaxoSmithKline

Articles by Matt Popkin, PhD

  • Analytical Methods and Control Strategies: The Forgotten Interface?

    Monday, February 02, 2015
    There is considerable interest in enhancing approaches for analytical method development, validation, and lifecycle management which are aligned with Quality by Design (QbD) approaches to drug development. These enhanced approaches utilize risk ...
  • <<
  • >>